FDA Approves First Biosimilar to Treat Multiple Sclerosis. News release. FDA. August 24, 2023. Accessed November 21, 2025. https://www.fda.gov/news …
Natalizumab Biosimilar Officially Launched in the United States | NeurologyLive
Share This Story, Choose Your Platform!
About the Author: AJDesign77
